Status:
COMPLETED
Peer Led Asthma Self Management for Adolescents: PLASMA
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
Johns Hopkins University
University of Tennessee
Conditions:
Asthma
Eligibility:
All Genders
12-20 years
Phase:
PHASE2
Brief Summary
Asthma is a serious chronic health condition particularly in inner-city adolescents, who suffer disproportionately high asthma-related morbidity and mortality that place heavy economic burdens on fami...
Detailed Description
Asthma, the most common pediatric chronic condition, is a serious problem for many adolescents. In 2010, nearly 11% of adolescents (2.7 million) ages 12 through 17 years in the US reported current ast...
Eligibility Criteria
Inclusion
- Eligibility criteria for adolescent (camp) participants include:
- age between 12-17 years;
- physician-diagnosed asthma that has required health service use (preventive or acute) within 12 months prior to recruitment;
- persistent asthma determined by current use of a control medication or presenting at least one of the following four symptom levels in the past 4 weeks, as defined by the NAEPP guidelines91:
- \> 2 days/week of daytime symptoms,
- \>3-4 times of nighttime awakening,
- \>2 days/week of SABA use, or
- any interference with normal activities due to asthma (4) Investigators will include those with chronic health conditions except for those with conditions affecting respiratory system, heart disease, pneumonia, etc., and those with moderate to severe cognitive impairments; (5) primary residence located in the participating inner cities based on zip codes; and (6) ability to understand spoken and written English.
- Eligibility criteria for peer leaders include:
- age between 16-20 years;
- nomination from school teachers/nurses or healthcare providers for candidates' exemplary asthma self-management, leadership, and emotional intelligence; and
- fulfillment of eligibility criteria (2)-(6) prescribed for adolescent participants.
Exclusion
- Adolescents who are pregnant or incarcerated at enrollment;
- Have learning disabilities based on reports from teachers or clinicians will be excluded from the study because such conditions can confound the interpretation of findings;
- Those who have serious health (other than asthma) and emotional preconditions (e.g., severe depression, anxiety disorders, schizophrenia).
Key Trial Info
Start Date :
May 14 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2019
Estimated Enrollment :
371 Patients enrolled
Trial Details
Trial ID
NCT02293499
Start Date
May 14 2015
End Date
February 28 2019
Last Update
April 8 2021
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University
Baltimore, Maryland, United States, 21205
2
University at Buffalo
Buffalo, New York, United States, 14203
3
University of Rochester Medical Center
Rochester, New York, United States, 14642
4
University of Tennessee
Memphis, Tennessee, United States, 38163